No, you won’t. The cannabinoid responsible for inducing a psychoactive effect (or “high”) is THC, not CBD. In broad-spectrum CBD that has been responsibly produced, the THC content will be below 0.03 percent. Note also that you can review the Certificate of Analysis for any CBMD® product by entering the item’s batch code into the search field in the COA section above.

A very general recommendation has been “between 20 and 1,500 milligrams (mg) per day” with a small starting dosage, and slowly increasing until the desired effect is attained. But, the ideal dosage will depend on a number of factors, including body weight and chemistry, the product’s CBD concentration, and the method of ingestion/absorption. The proper dosage is also dependent on the symptom for which one is using the product. For instance, our products targeting anxiety and inflammation come with unique dosage recommendations tailored to the respective mechanism.

The CBD industry currently lacks the kind of objective research clinicians would ideally rely upon to inform dosing. In the absence of any such concrete guidelines, consumers may attempt to monitor their own intake—a further complication given the high percentage of CBD products with substandard manufacturing protocols and inaccurate labeling.

CBMD® products are produced with rigorous oversight by our team of physicians. Our expertise in human physiology provides a contextual backdrop with regard to dosing. We further apply stringent measures in product development to ensure quality, consistency, and accuracy.

Our partnership with Cannabiomed and the network of physicians, scientists, researchers, and pharmacists with whom we work ensures that we are uniquely equipped to evolve our products as more data becomes available. Until the potential of CBD is revealed, we will continue our efforts so that clinicians and consumers have a responsible option for CBD products—today and in the future.

Yes. The passing of the 2018 Farm Bill (the Agriculture Improvement Act of 2018) legalized hemp and the extraction of CBD from the Cannabis sativa L. plant at the federal level. Under the Farm Bill, provided that these plants and derivatives do not contain more than 0.3 percent THC “on a dry weight basis,” they are no longer consider controlled substances under federal law. Because of this, hemp is now considered an agricultural commodity.

However, despite the federal legality, individual states are still able to establish their own laws. As of early 2021, CBD is legal or legal with restrictions in all but three states (North Dakota, Nebraska, and Iowa). The states where CBD is legal with restrictions are: Idaho, South Dakota, Missouri, Mississippi, Georgia, South Carolina and New Hampshire.

Hemp-derived CBD differs from CBD derived from marijuana, which is remains illegal at the federal level. CBMD® products are formulated exclusively with hemp-derived CBD.

Lastly, an important point to bear in mind is that the legality of CBD does not ensure that manufacturers are following safe practices. Because the FDA does not regulate CBD currently, the market is flooded with products that are incorrectly labeled (having much more or less CBD than stated), have an illegal amount of THC, and contain unsafe solvents, pesticides, heavy metals, and even mold. CBMD® offers an alternative to these unregulated products. We provide a trackable batch number on each product. Entering the batch number on our website will show the certificate of analysis for each unique batch.